Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||1.59%||182.51||0.7%||$1411.48m|
|MRK||Merck & Co., Inc.||1.39%||93.28||0.7%||$1241.52m|
|BMY||Bristol-Myers Squibb Co.||1.67%||78.99||1.0%||$1137.41m|
|LLY||Eli Lilly & Co.||4.15%||325.69||1.1%||$1136.04m|
|TPTX||Turning Point Therapeutics, Inc.||0.03%||75.17||0.0%||$291.93m|
|SIGA||SIGA Technologies, Inc.||-0.46%||13.04||0.0%||$219.68m|
|MRTX||Mirati Therapeutics, Inc.||3.45%||68.16||1.6%||$199.41m|
|HZNP||Horizon Therapeutics Plc||2.68%||85.13||5.4%||$182.59m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||-0.14%||144.00||0.0%||$147.86m|
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.